Article Information
History
- March 7, 2023.
Article Versions
- Version 1 (March 6, 2023 - 16:29).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Danya J. Martell1,2,3,4,
- Hope E. Merens1,
- Claudia Fiorini2,3,4,
- Alexis Caulier2,3,4,
- Jacob C. Ulirsch2,3,4,
- Robert Ietswaart1,
- Karine Choquet1,
- Giovanna Graziadei5,
- Valentina Brancaleoni5,
- Maria Domenica Cappellini5,
- Caroline Scott6,
- Nigel Roberts7,
- Melanie Proven8,
- Noémi BA Roy6,9,10,
- Christian Babbs6,
- Douglas R. Higgs6,
- Vijay G. Sankaran2,3,4,# and
- L. Stirling Churchman1,#
- 1Harvard University, Department of Genetics, Boston, MA,
- 2Division of Hematology/Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA,
- 3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA,
- 4Broad Institute of MIT and Harvard, Cambridge, MA,
- 5Department of Clinical Sciences and Community, University of Milan, IRCCS Ca’Granda Foundation Maggiore Policlinico Hospital, Milan, Italy,
- 6MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom,
- 7MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK,
- 8Oxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK,
- 9NIHR Oxford Biomedical Research Centre and BRC/NHS Translational Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK,
- 10Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- ↵#Corresponding authors; email: churchman{at}genetics.med.harvard.edu